Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Am J Kidney Dis. 2008 Jul 21;52(6):1042–1050. doi: 10.1053/j.ajkd.2008.05.015

Table 1.

Comparison of demographic characteristics of patients with various sequence variant categories and patients with a positive family history of ADPKD.

De novo Sequence variant Unknown sequence variant Possible pathologic DNA variant ADPKD diagnosis in parental generation Positive family history of ADPKD
No. 6 10 4 4 688
Women 67% 50% 75% 50% 61%
Age (years) at clinical evaluation 39 ± 1 43 ± 8 37 ± 5 26 ± 11 34 ± 16
Paternal age range (years) at clinical evaluation 65–74 50–87 58–80 31–81
Age at diagnosis (y) 24 ± 5 37 ± 4* 36 ± 7 21 ± 7 25 ± 1
Hypertension 67% 90% 75% 50% 69%
Age at hypertension diagnosis (years) 25 ± 6 32 ± 4 39 ± 7 3a 31 ± 1
Serum creatinine (mg/dl) b (median) 1.7 ± 0.4 (1.3) 2.3 ± 0.3 (1.7) 1.3 ± 0.5 (1.3) 1.0 ± 0.5(0.7) 1.5 ± 0.1 (1.0)
Creatinine clearance (ml/min/1.73m2) c (median) 80 ± 12 (69) 72 ± 9 (61) 99 ± 17 (97) 103 ± 17 (106) 83 ± 1 (86)
Renal volume (cm3) b (median) 702 ± 219 (695) 698 ± 169 (918) 249 ± 310 (321) 413 ± 268 (237) 684 ± 21 (449)
Liver cysts 100% 60% 75% 25% 50%
 Mend 100% 60% 0% 0% 44%
 Womend 100% 60% 100% 50% 55%
Severe liver cystic diseasee (> 15 liver cysts) 83%* 40% 50%** 25% 25%
 Menf 50% 40% 0% 0% 18%
 Womenf 100% 40% 67% 50% 30%
Ruptured intracranial aneurysm 0% 10% 0% 0% 2.4%

Note: To convert serum creatinine in mg/dl to μmol/L, multiply by 88.4; to convert creatinine clearance in ml/min/1.73 m2 to ml/s/1.73 m2, multiply by 0.01667.

*

P < 0.05

**

P <0.001

a

Age at hypertension diagnosis only available for 1 patient.

b

Age and sex adjusted

c

Age adjusted.

d

% Total number of patients with liver cysts

e

>15 cysts of varying size with evidence of 1–25% reduction in normal liver parenchyma

f

% Total number of men or women patients with liver cysts who have severe liver cystic disease